PT - JOURNAL ARTICLE AU - Maria G. Prado AU - Larry G. Kessler AU - Margaret A. Au AU - Hannah A. Burkhardt AU - Monica Zigman Suchsland AU - Lesleigh Kowalski AU - Kari A. Stephens AU - Meliha Yetisgen AU - Fiona M. Walter AU - Richard D. Neal AU - Kevin Lybarger AU - Caroline A. Thompson AU - Morhaf Al Achkar AU - Elizabeth A. Sarma AU - Grace Turner AU - Farhood Farjah AU - Matthew Thompson TI - Symptoms and signs of lung cancer prior to diagnosis: Comparative study using electronic health records AID - 10.1101/2022.06.01.22275657 DP - 2022 Jan 01 TA - medRxiv PG - 2022.06.01.22275657 4099 - http://medrxiv.org/content/early/2022/06/02/2022.06.01.22275657.short 4100 - http://medrxiv.org/content/early/2022/06/02/2022.06.01.22275657.full AB - Background Lung cancer is the most common cause of cancer-related death in the United States (US), with most patients diagnosed at later stages (3 or 4). While most patients are diagnosed following symptomatic presentation, no studies have compared symptoms and physical examination signs at or prior to diagnosis from electronic health records (EHR) in the United States (US).Objective To identify symptoms and signs in patients prior to lung cancer diagnosis in EHR data.Study Design Case-control study.Methods We studied 698 primary lung cancer cases in adults diagnosed between January 1, 2012 and December 31, 2019, and 6,841 controls matched by age, sex, smoking status, and type of clinic. Coded and free-text data from the EHR were extracted from 2 years prior to diagnosis date for cases and index date for controls. Univariate and multivariate conditional logistic regression were used to identify symptoms and signs associated with lung cancer. Analyses were repeated excluding symptom data from 1, 3, 6, and 12 months before the diagnosis/index dates.Results Eleven symptoms and signs recorded during the study period were associated with a significantly higher chance of being a lung cancer case in multivariate analyses. Of these, seven were significantly associated with lung cancer six months prior to diagnosis: hemoptysis (OR 3.2, 95%CI 1.9-5.3), cough (OR 3.1, 95%CI 2.4-4.0), chest crackles or wheeze (OR 3.1, 95%CI 2.3-4.1), bone pain (OR 2.7, 95%CI 2.1-3.6), back pain (OR 2.5, 95%CI 1.9-3.2), weight loss (OR 2.1, 95%CI 1.5-2.8) and fatigue (OR 1.6, 95%CI 1.3-2.1).Conclusions Patients diagnosed with lung cancer appear to have symptoms and signs recorded in the EHR that distinguish them from similar matched patients in ambulatory care, often six months or more before their diagnosis. These findings suggest opportunities to improve the diagnostic process for lung cancer in the US.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Gordon and Betty Moore Foundation (GBMF8837) and the CanTest Collaborative, funded by Cancer Research UK (RG85791).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Human Subjects Division/IRB of the University of Washington gave ethical approval for this work (STUDY 000013191).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.CACTCOVID-19 Annotated Clinical Text CorpusCPTCurrent Procedural TerminologyCRDChronic respiratory diseaseEDWEnterprise-wide data warehouseEHRElectronic health recordsICDInternational Classification of DiseasesLACTLung Cancer Annotated Clinical Text CorpusLDCTLow-dose computed tomographyNLPNatural language processingSEERSeattle/Puget Sound Surveillance, Epidemiology, and End ResultsUWMUniversity of Washington Medicine